Development of novel therapies for MG: Studies in animal models.
Souroujon
M C
MC
Department of Natural Sciences, The Open University of Israel, Raanana 43104, Israel. miriso@openu.ac.il
Brenner
T
T
Fuchs
S
S
D000818:Animals; D001781:Blood Component Removal; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000628:therapy*; D020720:Myasthenia Gravis, Autoimmune, Experimental / Q000188:drug therapy / Q000628:therapy*; D011950:Receptors, Cholinergic / Q000276:immunology; D035703:Therapies, Investigational
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic